All In MedTech

Device Trial Radar · NCT06474845

Efficacy of the T-Control® Catheter Compared to the Foley-type Catheter in Patients With Long-term Catheterization

Multicentre International Randomized Clinical Study to Assess the Efficacy of the T-Control® Catheter vs. a Conventional Foley-type Catheter

Last checked: Nov 21, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

12

Actual

Start

Feb 10, 2024

Primary completion

May 1, 2026

Study completion Sep 1, 2026

Sponsor

Lead sponsor
Rethink Medical SLNot on our public-company list
Sponsor type
Industry
Collaborators
Evidenze CRO; Centro para el Desarrollo Tecnológico y la Innovación (CDTI), Spain
First posted
Jun 26, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if the new urinary catheter T-Control® allows a reduction in infections associated with urinary catheters and a better quality of life of urinary catheter patients compared to the conventional Foley-type catheter (the currently used in clinical practice). It will also learn about the safety profile of the T-Control® catheter and its cost-effectiveness. The main questions it aims to answer are: Does the T-Control® catheter lower the number of infections of the patients who need long-term catheterization? Does he T-Control® catheter implies a better perceived quality of life of long-term catheterization patients? Participants will: Be catheterized with T-Control® or Foley catheter. Visit the clinic after 4 weeks for checkups, fullfill questionnaires and tests. Keep a diary of their symptoms and adverse events related to the catheter.

Conditions

  • Catheter; Infection (Indwelling Catheter)
  • Quality of Life
  • Catheter Related Complication

Interventions

  • T-Control® catheterDevice

    Patients will be catheterized with T-Control® for 4 weeks

  • Foley-type catheterDevice

    Patients will be catheterized with a conventional Foley-type catheter for 4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Catheter-Associated Urinary Tract Infections (symptomatic and asymptomatic)Time frame: 4 weeks

1 more outcomes with a free account

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • Prof. Doutor Fernando Fonseca Hospital

    Amadora, Portugal

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.